Limits...
The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma.

Shen ED, Liu B, Yu XS, Xiang ZF, Huang HY - Onco Targets Ther (2016)

Bottom Line: After 48 hours of cisplatin treatment, CCK-8 method was used to detect cell proliferation and flow cytometry were performed to examine cell apoptosis. miR-1207-5p expression in peripheral blood was significantly associated with tumor node metastasis staging of PGBC (P<0.05).The rates of positive expression of Ki67 protein in the effective group were significantly lower than those in the ineffective group (P<0.05).The concentration and action time of cisplatin were negatively associated with the cell survival rate in each group (all P<0.05).

View Article: PubMed Central - PubMed

Affiliation: Department of Oncology, The First People's Hospital of Yueyang, Yueyang.

ABSTRACT

Objective: The aim of this study was to investigate the association between miR-1207-5p expression in peripheral blood and the chemosensitivity of primary gallbladder carcinoma (PGBC).

Methods: A total of 85 patients with PGBC undergoing preoperative chemotherapy were divided into effective (n=18) and ineffective (n=67) groups. Another 70 healthy individuals were selected as the control group. An miR-1207-5p mimic (mimic group), an inhibitor (inhibitor group), and a negative control (NC group) sequence were transfected into human gallbladder carcinoma GBC-SD cells. Real-time quantitative polymerase chain reaction was used to determine miR-1207-5p expression. After 48 hours of cisplatin treatment, CCK-8 method was used to detect cell proliferation and flow cytometry were performed to examine cell apoptosis.

Results: miR-1207-5p expression in peripheral blood was significantly associated with tumor node metastasis staging of PGBC (P<0.05). Before chemotherapy, miR-1207-5p expression in patients was higher than in healthy individuals (P<0.05). After chemotherapy, the effective group had lower miR-1207-5p expression than the ineffective group (P<0.05). The rates of positive expression of Ki67 protein in the effective group were significantly lower than those in the ineffective group (P<0.05). Receiver operating characteristic curves showed that the area under curve, sensitivity, and specificity of miR-1207-5p used to diagnose PGBC were 0.898, 77.6%, and 97.1% at a cutoff of 1.470, respectively. After 48 hours of cisplatin treatment, compared with the NC group and nontransfected (non-T) group, the mimic group had decreased rates of cell inhibition and apoptosis, but the inhibitor group had increased rates (all P<0.05). The expression levels of caspase3 protein were increased in the mimic group and decreased in the inhibitor group. Cell survival rates in the mimic group at different time points after cisplatin treatment were significantly higher than the corresponding rates in the NC and non-T groups, whereas the cell survival rates in the inhibitor group were significantly lower than the rates in the NC and non-T groups (all P<0.05). The concentration and action time of cisplatin were negatively associated with the cell survival rate in each group (all P<0.05).

Conclusion: Cisplatin-based chemosensitivity of PGBC increased as expression of miR-1207-5p in peripheral blood declined. Thus, miR-1207-5p appears to be a promising and novel chemosensitizer for the treatment of PGBC.

No MeSH data available.


Related in: MedlinePlus

miR-1207-5p expression in the peripheral blood of patients with primary gallbladder carcinoma in the effective and ineffective groups before and after chemotherapy and in the control group.Notes: *P<0.05 compared with the control group. #P<0.05 when prechemotherapy was compared with postchemotherapy. &P<0.05 when the effective group (CR + PR) was compared with the ineffective group (PD + SD) both pre- and postchemotherapy.Abbreviations: CR, complete remission; PR, partial remission; PD, progressive disease; SD, stable disease.
© Copyright Policy
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4920227&req=5

f2-ott-9-3633: miR-1207-5p expression in the peripheral blood of patients with primary gallbladder carcinoma in the effective and ineffective groups before and after chemotherapy and in the control group.Notes: *P<0.05 compared with the control group. #P<0.05 when prechemotherapy was compared with postchemotherapy. &P<0.05 when the effective group (CR + PR) was compared with the ineffective group (PD + SD) both pre- and postchemotherapy.Abbreviations: CR, complete remission; PR, partial remission; PD, progressive disease; SD, stable disease.

Mentions: RT-qPCR analysis showed that miR-1207-5p was overexpressed in both the effective and ineffective groups compared with the control group before chemotherapy (both P<0.05). After chemotherapy, miR-1207-5p expression in both the effective and ineffective groups declined (both P<0.05), and expression was significantly lower in the effective group than in the ineffective group (0.917± standard deviation 0.318 vs 1.074± standard deviation 0.289, P<0.05). Expression in the effective group was slightly higher (P>0.05), although the ineffective group had significantly higher miR-1207-5p expression (P<0.05) than the control group (Figure 2).


The effects of miR-1207-5p expression in peripheral blood on cisplatin-based chemosensitivity of primary gallbladder carcinoma.

Shen ED, Liu B, Yu XS, Xiang ZF, Huang HY - Onco Targets Ther (2016)

miR-1207-5p expression in the peripheral blood of patients with primary gallbladder carcinoma in the effective and ineffective groups before and after chemotherapy and in the control group.Notes: *P<0.05 compared with the control group. #P<0.05 when prechemotherapy was compared with postchemotherapy. &P<0.05 when the effective group (CR + PR) was compared with the ineffective group (PD + SD) both pre- and postchemotherapy.Abbreviations: CR, complete remission; PR, partial remission; PD, progressive disease; SD, stable disease.
© Copyright Policy
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4920227&req=5

f2-ott-9-3633: miR-1207-5p expression in the peripheral blood of patients with primary gallbladder carcinoma in the effective and ineffective groups before and after chemotherapy and in the control group.Notes: *P<0.05 compared with the control group. #P<0.05 when prechemotherapy was compared with postchemotherapy. &P<0.05 when the effective group (CR + PR) was compared with the ineffective group (PD + SD) both pre- and postchemotherapy.Abbreviations: CR, complete remission; PR, partial remission; PD, progressive disease; SD, stable disease.
Mentions: RT-qPCR analysis showed that miR-1207-5p was overexpressed in both the effective and ineffective groups compared with the control group before chemotherapy (both P<0.05). After chemotherapy, miR-1207-5p expression in both the effective and ineffective groups declined (both P<0.05), and expression was significantly lower in the effective group than in the ineffective group (0.917± standard deviation 0.318 vs 1.074± standard deviation 0.289, P<0.05). Expression in the effective group was slightly higher (P>0.05), although the ineffective group had significantly higher miR-1207-5p expression (P<0.05) than the control group (Figure 2).

Bottom Line: After 48 hours of cisplatin treatment, CCK-8 method was used to detect cell proliferation and flow cytometry were performed to examine cell apoptosis. miR-1207-5p expression in peripheral blood was significantly associated with tumor node metastasis staging of PGBC (P<0.05).The rates of positive expression of Ki67 protein in the effective group were significantly lower than those in the ineffective group (P<0.05).The concentration and action time of cisplatin were negatively associated with the cell survival rate in each group (all P<0.05).

View Article: PubMed Central - PubMed

Affiliation: Department of Oncology, The First People's Hospital of Yueyang, Yueyang.

ABSTRACT

Objective: The aim of this study was to investigate the association between miR-1207-5p expression in peripheral blood and the chemosensitivity of primary gallbladder carcinoma (PGBC).

Methods: A total of 85 patients with PGBC undergoing preoperative chemotherapy were divided into effective (n=18) and ineffective (n=67) groups. Another 70 healthy individuals were selected as the control group. An miR-1207-5p mimic (mimic group), an inhibitor (inhibitor group), and a negative control (NC group) sequence were transfected into human gallbladder carcinoma GBC-SD cells. Real-time quantitative polymerase chain reaction was used to determine miR-1207-5p expression. After 48 hours of cisplatin treatment, CCK-8 method was used to detect cell proliferation and flow cytometry were performed to examine cell apoptosis.

Results: miR-1207-5p expression in peripheral blood was significantly associated with tumor node metastasis staging of PGBC (P<0.05). Before chemotherapy, miR-1207-5p expression in patients was higher than in healthy individuals (P<0.05). After chemotherapy, the effective group had lower miR-1207-5p expression than the ineffective group (P<0.05). The rates of positive expression of Ki67 protein in the effective group were significantly lower than those in the ineffective group (P<0.05). Receiver operating characteristic curves showed that the area under curve, sensitivity, and specificity of miR-1207-5p used to diagnose PGBC were 0.898, 77.6%, and 97.1% at a cutoff of 1.470, respectively. After 48 hours of cisplatin treatment, compared with the NC group and nontransfected (non-T) group, the mimic group had decreased rates of cell inhibition and apoptosis, but the inhibitor group had increased rates (all P<0.05). The expression levels of caspase3 protein were increased in the mimic group and decreased in the inhibitor group. Cell survival rates in the mimic group at different time points after cisplatin treatment were significantly higher than the corresponding rates in the NC and non-T groups, whereas the cell survival rates in the inhibitor group were significantly lower than the rates in the NC and non-T groups (all P<0.05). The concentration and action time of cisplatin were negatively associated with the cell survival rate in each group (all P<0.05).

Conclusion: Cisplatin-based chemosensitivity of PGBC increased as expression of miR-1207-5p in peripheral blood declined. Thus, miR-1207-5p appears to be a promising and novel chemosensitizer for the treatment of PGBC.

No MeSH data available.


Related in: MedlinePlus